CNSP — CNS Pharmaceuticals Share News
0.000.00%
Brief: Nasdaq Halts CNS Pharmaceuticals Inc
Brief: CNS Pharma - Nasdaq Has Halted Trading In Co's Common Stock
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 02:59 AM
Brief: Cns Pharmaceuticals - Learned Certain Third Parties Distributed Statements, Information Between March 20-May 5 About Wp1122
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 02:59 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 02:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 02:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 02:59 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 02:59 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:01 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 02:59 AM
NASDAQ TRADE HALT HALT SEC TRADING SUSPENSION AT 08:28 AM
CNS Pharma: Jumps on orphan drug designation application for cancer drug
Brief: Cns Pharmaceuticals Says University Research Confirms Active Compound In WP1122 Completely Prevents Coronavirus Replication In Vitro
Brief: WPD Pharmaceuticals Partners With CNS Pharmaceuticals On Drug Development For Coronavirus And Other Antiviral Indications
Brief: CNS Pharmaceuticals Reports Quarterly Loss Per Share Of $0.17
U.S. STOCKS ON THE MOVE-HanesBrands, Boingo Wireless, AngloGold Ashanti, Can-Fite
U.S. STOCKS ON THE MOVE-Stealth Bio, Harmony Gold, Inovio Pharma, NCS Multistage